Drug Research

Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, have announced a partnership to support Crinetics’ CRN04894 pediatric program. The partnership will utilize Quotient Sciences’ unique Translational...

Intrathecal (IT), intravenous (IV), and Nivolumab (anti-PD-1) immunotherapy were found to be safe and prolong life in a subset of melanoma individuals with leptomeningeal illness (LMD). The interim evaluations of the innovative delivery strategy were presented in the first-in-human Phase...

The European Medicines Agency (EMA) has released a paper summarizing its Regulatory Science Strategy (RSS) mid-point achievements through 2025. Originally released in March 2020, the strategy outlines a five-year goal for advancing regulatory science. Regulatory science belongs to the scientific...

Researchers have identified a molecule that is particularly successful in preventing sickness caused by all known forms of the SARS-CoV-2 virus when put nasally. The molecule could be a valuable tool in preparing for future pandemics because it is...

In the final draft guidance rolled out by the National Institute for Health and Care Excellence- NICE, a single-dose therapy, eladocagene exuparvovec, has been recommended for patients who are more than 18 months old and happen to be suffering...

More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the condition with the anti-seizure medications that are currently in use. The patients with such drug-resistant...

Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand. The company will invest over KRW...